UV Germi SA
UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of air, water, and surfaces in France. The company offers its products in the areas of drinking water, seawater, dechloramination, wastewater and industrial process water, private pool, legionella, germiserre, small flow rates, ageing, industrial clean water, and livestock farming industries. It also provides after… Read more
UV Germi SA (ALUVI) - Total Liabilities
Latest total liabilities as of June 2025: €1.26 Million EUR
Based on the latest financial reports, UV Germi SA (ALUVI) has total liabilities worth €1.26 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UV Germi SA - Total Liabilities Trend (2014–2024)
This chart illustrates how UV Germi SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UV Germi SA Competitors by Total Liabilities
The table below lists competitors of UV Germi SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
|
USA | $804.97K |
|
Phoslock Environmental Technologies Ltd
AU:PET
|
Australia | AU$348.00K |
|
Saranacentral Bajatama Tbk
JK:BAJA
|
Indonesia | Rp638.85 Billion |
|
Destiny Media Technologies Inc
OTCQB:DSNY
|
USA | $496.86K |
|
Pangea Natural Foods Inc.
OTCQB:PNGAF
|
USA | $521.73K |
|
Eurocastle Investment Limited
OTCGREY:EUIVF
|
USA | $90.37 Million |
|
KEYENCE CORP
MU:KEE
|
Germany | €165.94 Billion |
|
Polychem Indonesia Tbk
JK:ADMG
|
Indonesia | Rp44.23 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down UV Germi SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UV Germi SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UV Germi SA (2014–2024)
The table below shows the annual total liabilities of UV Germi SA from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.18 Million | -8.39% |
| 2023-12-31 | €1.29 Million | -36.19% |
| 2022-12-31 | €2.02 Million | +7.75% |
| 2021-12-31 | €1.87 Million | -34.86% |
| 2020-12-31 | €2.88 Million | +33.96% |
| 2019-12-31 | €2.15 Million | +10.30% |
| 2018-12-31 | €1.95 Million | +19.01% |
| 2017-12-31 | €1.64 Million | +13.53% |
| 2016-12-31 | €1.44 Million | -9.10% |
| 2015-12-31 | €1.59 Million | +102.46% |
| 2014-12-31 | €783.39K | -- |